Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome vs ropivacaine for recovery after laparoscopic cholecystectomy
ChiCTR2400090767Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cholelithiasis, cholecystitis and gallbladder polyp comparing Bupivacaine liposome injection group with Ropivacaine hydrochloride injection group (2 arms). Primary endpoint: Quality of Recovery-15 (QoR-15) score. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
cholelithiasischolecystitisgallbladder polyp
Beyond the preview
Go deeper on ChiCTR2400090767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090767.